Sanofi's Dupixent Emerges as First Biologic Treatment for COPD in China, Pioneering a New Era in Respiratory Medicine
Sep 28, 2024
Dupixent Equities
Sanofi's Dupixent Secures EU Approval as Novel COPD Therapy
Jul 4, 2024